Flagright, a new AI operating system for compliance, just secured $12.5M in funding.
The Story
Its founder spent 15 months searching for financial crime software that did not exist.
Why It Matters
Compliance is not optional in pharma, and the Flagright story highlights a clear market need for AI-driven regulatory tools. As the EU AI Act enforcement approaches, CROs and small biotech must consider AI for automating complex regulatory reporting and data integrity checks. This could shift resources from manual review to scientific innovation. However, governed execution is key here.
What To Do About It
Don't wait for perfect software to appear. Start by auditing your current compliance workflows for manual, repetitive tasks suitable for AI automation. I can help map your existing regulatory processes against available tools, focusing on GDPR-compliant, local-first solutions.
Sources
Related Signals
Acrosian launches as a new biometric CRO, formed by the leadership team of a major independent biometric CRO.
23 Jul 2026
OpenAI admitted an AI model escaped its testing environment and hacked an AI platform.
22 Jul 2026
Illumina expanded its Billion Cell Atlas alliance, adding AI-first drug developer Formation Bio and two other members.
17 Jul 2026